Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?
Autor(a) principal: | |
---|---|
Data de Publicação: | 2008 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Journal of epilepsy and clinical neurophysiology (Online) |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009 |
Resumo: | INTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug. |
id |
LBE-1_4860e7675c651cce918f404811e83c9a |
---|---|
oai_identifier_str |
oai:scielo:S1676-26492008000300009 |
network_acronym_str |
LBE-1 |
network_name_str |
Journal of epilepsy and clinical neurophysiology (Online) |
repository_id_str |
|
spelling |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs?Subclinical dischargesLandau-Kleffner Syndromespeech delayINTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug.Liga Brasileira de Epilepsia (LBE)2008-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009Journal of Epilepsy and Clinical Neurophysiology v.14 n.3 2008reponame:Journal of epilepsy and clinical neurophysiology (Online)instname:Liga Brasileira de Epilepsia (LBE)instacron:LBE10.1590/S1676-26492008000300009info:eu-repo/semantics/openAccessLiberalesso,Paulo Breno NoronhaNascimento,Lincoln FransciscoKlagenberg,Karlin FabianneJurkiewicz,Ari LeonZeigelboim,Bianca Simoneeng2009-01-05T00:00:00Zoai:scielo:S1676-26492008000300009Revistahttp://epilepsia.org.br/publicacoes/ONGhttps://old.scielo.br/oai/scielo-oai.php||jecnpoa@terra.com.br1980-53651676-2649opendoar:2009-01-05T00:00Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE)false |
dc.title.none.fl_str_mv |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
title |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
spellingShingle |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? Liberalesso,Paulo Breno Noronha Subclinical discharges Landau-Kleffner Syndrome speech delay |
title_short |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
title_full |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
title_fullStr |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
title_full_unstemmed |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
title_sort |
Landau-Kleffner syndrome without seizures: would speech delay justify the treatment with antiepileptic drugs? |
author |
Liberalesso,Paulo Breno Noronha |
author_facet |
Liberalesso,Paulo Breno Noronha Nascimento,Lincoln Franscisco Klagenberg,Karlin Fabianne Jurkiewicz,Ari Leon Zeigelboim,Bianca Simone |
author_role |
author |
author2 |
Nascimento,Lincoln Franscisco Klagenberg,Karlin Fabianne Jurkiewicz,Ari Leon Zeigelboim,Bianca Simone |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Liberalesso,Paulo Breno Noronha Nascimento,Lincoln Franscisco Klagenberg,Karlin Fabianne Jurkiewicz,Ari Leon Zeigelboim,Bianca Simone |
dc.subject.por.fl_str_mv |
Subclinical discharges Landau-Kleffner Syndrome speech delay |
topic |
Subclinical discharges Landau-Kleffner Syndrome speech delay |
description |
INTRODUCTION: Landau-Kleffner Syndrome is a rare epileptic syndrome characterized by the association of receptive aphasia, epileptic seizures, behavioral disorders and electroencephalographic changes with discharges at the temporal lobe unilaterally or bilaterally. Seizures are not essential for diagnosis. CASE REPORT: J. V. S. S., 3 y/o male, with delay in acquirement of speech, psychomotor agitation and sleep disorder (sleeplessness). Attempt to communicate was established by gestures and pointing at things. His behavior characterized by agitation, restlessness, aggressiveness and difficulty to establish social contact with other children by the same age. MRI was normal and the EEG showed sharp-wave discharges in the left medial and posterior temporal regions. After three months of treatment with carbamazepine the child returned to an evaluation, presenting substantial improvement at speech, speaking simple words and with meaningful improvement on both behavioral and sleep patterns, as well as, social interaction. DISCUSSION: Expression and reception speech disorders are relatively common in children with different epileptic syndromes, particularly in Landau-Kleffner syndrome. Epileptiform discharges can occur in people without epilepsy and use to be called subclinical discharges. What would be the impact of subclinical discharges on this population remains uncertain at the present time. We reviewed these interactions in the light of a representative case, showing favorable outcome following introduction of an antiepileptic drug. |
publishDate |
2008 |
dc.date.none.fl_str_mv |
2008-09-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1676-26492008000300009 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1590/S1676-26492008000300009 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Liga Brasileira de Epilepsia (LBE) |
publisher.none.fl_str_mv |
Liga Brasileira de Epilepsia (LBE) |
dc.source.none.fl_str_mv |
Journal of Epilepsy and Clinical Neurophysiology v.14 n.3 2008 reponame:Journal of epilepsy and clinical neurophysiology (Online) instname:Liga Brasileira de Epilepsia (LBE) instacron:LBE |
instname_str |
Liga Brasileira de Epilepsia (LBE) |
instacron_str |
LBE |
institution |
LBE |
reponame_str |
Journal of epilepsy and clinical neurophysiology (Online) |
collection |
Journal of epilepsy and clinical neurophysiology (Online) |
repository.name.fl_str_mv |
Journal of epilepsy and clinical neurophysiology (Online) - Liga Brasileira de Epilepsia (LBE) |
repository.mail.fl_str_mv |
||jecnpoa@terra.com.br |
_version_ |
1754734659502080000 |